Max Healthcare a Potential Multibagger? | Max Healthcare share analysis 2023
Max Healthcare is a leading healthcare provider in India. It is a network of hospitals and medical facilities that offer a wide range of medical services and treatments. Max Healthcare is known for its high-quality healthcare services, state-of-the-art infrastructure, and a team of experienced doctors and healthcare professionals.
00:00 Introduction
00:45 Max Healthcare Business Model
02:40 Max Healthcare Current Facilities
04:10 Max Healthcare Operational Numbers
05:57 Max Healthcare Consistency in Revenues and Margins
07:08 Max Healthcare Comparative Analysis (FY23)
08:27 Max Healthcare Vision Ahead
09:57 Max Healthcare Valuations
Complete Fundamental Stock Analysis Tool - Stock-o-meter:
https://investyadnya.in/stock-o-meter
Research Based Ready-made Model Portfolios:
https://investyadnya.in/model-portfolios
Comprehensive Mutual Fund Reviews:
https://investyadnya.in/fund-o-meter
Yadnya Books and eBooks now available:
On Amazon - https://amzn.to/2XKtlks
On our website - https://investyadnya.in/books
Find us on Social Media and stay connected:
Blog - https://blog.investyadnya.in
Telegram - http://t.me/InvestYadnya
Facebook Page - https://www.facebook.com/InvestYadnya
Facebook Group - https://goo.gl/y57Qcr
Twitter - https://www.twitter.com/InvestYadnya
LinkedIn - https://www.linkedin.com/company/investyadnya/
#InvestYadnya #YIA
#healthcare #maxhealthcare #hospital
LEGAL DISCLAIMER:
Use of this information is at the user's own risk. The Company and its directors, associates and employees will not be liable for any loss or liability incurred to the user due to investments made or decisions taken based on the information provided herein. The investment discussed or views expressed herein may not be suitable for all investors. The users should rely on their own research and analysis and should consult their investment advisors to determine the merit, risks and suitability of recommendation. Past performance is not a guarantee for future performance or future results. Information herein is believed to be reliable, although its accuracy and completeness cannot be guaranteed. The images used may be copyright of the company or third party. As a condition to using the services, the user agrees to the terms of use of the website and the services.
DISCLOSURES UNDER SEBI (RESEARCH ANALYST) REGULATIONS, 2014:
Yadnya Academy Pvt. Ltd. (InvestYadnya) is registered with SEBI under SEBI (Research Analyst) Regulations, 2014 with registration no. INH000008349.
Disclosure with regard to ownership and material conflicts of interest
1. Neither Research Analyst nor the entity nor his associates or relatives have any financial interest in the subject Company;
2. Neither Research Analyst nor the entity nor its associates or relatives have actual / beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report or date of public appearance;
3. Neither Research Analyst nor the entity nor its associates or his relatives have any other material conflict of interest at the time of publication of the research report or at the time of public appearance.
Disclosure with regard to receipt of Compensation
1. The Research Entity and its associates have not received compensation from the subject company in the past twelve months.
2. The subject company is not or was not a client during the twelve months preceding the date of recommendation.
Видео Max Healthcare a Potential Multibagger? | Max Healthcare share analysis 2023 канала Yadnya Investment Academy
00:00 Introduction
00:45 Max Healthcare Business Model
02:40 Max Healthcare Current Facilities
04:10 Max Healthcare Operational Numbers
05:57 Max Healthcare Consistency in Revenues and Margins
07:08 Max Healthcare Comparative Analysis (FY23)
08:27 Max Healthcare Vision Ahead
09:57 Max Healthcare Valuations
Complete Fundamental Stock Analysis Tool - Stock-o-meter:
https://investyadnya.in/stock-o-meter
Research Based Ready-made Model Portfolios:
https://investyadnya.in/model-portfolios
Comprehensive Mutual Fund Reviews:
https://investyadnya.in/fund-o-meter
Yadnya Books and eBooks now available:
On Amazon - https://amzn.to/2XKtlks
On our website - https://investyadnya.in/books
Find us on Social Media and stay connected:
Blog - https://blog.investyadnya.in
Telegram - http://t.me/InvestYadnya
Facebook Page - https://www.facebook.com/InvestYadnya
Facebook Group - https://goo.gl/y57Qcr
Twitter - https://www.twitter.com/InvestYadnya
LinkedIn - https://www.linkedin.com/company/investyadnya/
#InvestYadnya #YIA
#healthcare #maxhealthcare #hospital
LEGAL DISCLAIMER:
Use of this information is at the user's own risk. The Company and its directors, associates and employees will not be liable for any loss or liability incurred to the user due to investments made or decisions taken based on the information provided herein. The investment discussed or views expressed herein may not be suitable for all investors. The users should rely on their own research and analysis and should consult their investment advisors to determine the merit, risks and suitability of recommendation. Past performance is not a guarantee for future performance or future results. Information herein is believed to be reliable, although its accuracy and completeness cannot be guaranteed. The images used may be copyright of the company or third party. As a condition to using the services, the user agrees to the terms of use of the website and the services.
DISCLOSURES UNDER SEBI (RESEARCH ANALYST) REGULATIONS, 2014:
Yadnya Academy Pvt. Ltd. (InvestYadnya) is registered with SEBI under SEBI (Research Analyst) Regulations, 2014 with registration no. INH000008349.
Disclosure with regard to ownership and material conflicts of interest
1. Neither Research Analyst nor the entity nor his associates or relatives have any financial interest in the subject Company;
2. Neither Research Analyst nor the entity nor its associates or relatives have actual / beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report or date of public appearance;
3. Neither Research Analyst nor the entity nor its associates or his relatives have any other material conflict of interest at the time of publication of the research report or at the time of public appearance.
Disclosure with regard to receipt of Compensation
1. The Research Entity and its associates have not received compensation from the subject company in the past twelve months.
2. The subject company is not or was not a client during the twelve months preceding the date of recommendation.
Видео Max Healthcare a Potential Multibagger? | Max Healthcare share analysis 2023 канала Yadnya Investment Academy
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Decoding Form 16: Essential Tips for Taxpayersकैसे होती है Mutual Funds मैं Insider Trading? Mutual Fund Monday | Gaurav JainCrude Oil - Understanding Entire Value ChainFY24 Results Summary - 8 Sectors Analyzed for Long TermBehavioral aspects of long term investing with Parimal AdeIndividual Retail Investors - Emerging as a Strong Participant in Stock Market| Parimal AdeBest of Knowledge Section 9Investing is boring process, let's not make it exciting | Parimal AdeHow Jockey Made Page Industries a Multi-Bagger Stock? (3 Reasons)Yield Curve Inversion - Why it is important?Reliance's Game Plan - The FMCG Industry's Biggest Disruptor | Reliance Next Big MoveNatural Gas Sector Analysis | Understanding CNG & LNG complete Supply ChainToday's Stock Market News - 30/06/2022 | Parimal AdeToday's Stock Market News - 02/12/2022 | Parimal Ade | Aaj ki Taaza KhabarAll you need to know about NPS (National Pension Scheme)Should you invest in US markets? | Parimal Ade & Aastha KhuranaInfo Edge - Are you Bullish or Bearish? Sunday Podcast | Mandar PurandareUnion Budget 2023-24 | Complete Analysis & Highlights in Personal Finance way | Parimal AdeMuthoot Finance Fundamental Analysis 2023Zero Cost Term Insurance vs Return of Premium Insurance